Cargando…
Effects of sodium‐glucose cotransporter 2 inhibitors on hypoglycaemia in brittle diabetic patients with decreased endogenous insulin secretion
AIMS: The effects of sodium‐glucose cotransporter 2 inhibitors (SGLT2Is) on fasting blood glucose concentration (FBG) in patients with unstable FBG despite undergoing intensive insulin therapy (IIT) remain unclear. This study aimed to identify the effects of SGLT2Is on unstable FBGs. MATERIALS AND M...
Autores principales: | Ogawa, Susumu, Nako, Kazuhiro, Ito, Sadayoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354752/ https://www.ncbi.nlm.nih.gov/pubmed/30815573 http://dx.doi.org/10.1002/edm2.44 |
Ejemplares similares
-
Stabilization of postprandial blood glucose fluctuations by addition of glucagon like polypeptide-analog administration to intensive insulin therapy
por: Ogawa, Susumu, et al.
Publicado: (2015) -
Lower urinary pH is useful for predicting renovascular disorder onset in patients with diabetes
por: Ogawa, Susumu, et al.
Publicado: (2015) -
Sodium–glucose cotransporter 2 inhibitor, tofogliflozin, shows better improvements of blood glucose and insulin secretion in patients with high insulin levels at baseline
por: Tobe, Kazuyuki, et al.
Publicado: (2017) -
An Effective Insulin Therapy in Combination With Sodium-Glucose Cotransporter 2 Inhibitors
por: Yanai, Hidekatsu, et al.
Publicado: (2019) -
Insulin enhances renal glucose excretion: relation to insulin sensitivity and sodium-glucose cotransport
por: Ferrannini, Ele, et al.
Publicado: (2020)